Skip to main content
. 2021 May 17;904:174193. doi: 10.1016/j.ejphar.2021.174193

Fig. 1.

Fig. 1

Plasma level of IL-2 (A) and IFN-γ (B) from patients with mild and moderate COVID-19 infection in the control and melatonin cohorts. Data presented as the median (min, max) percent of baseline.